Applying imaging biomarkers and radiomics to cancer discovery, our efforts center on advancing precision imaging in personalized medicine for improved cancer patient care.
Our Group
The Radiomics Group was set up at VHIO in October 2017 with the aim of developing novel image biomarkers in oncology and since then it has incorporated more than 9 team members.
